Načítá se...
Stroke Prevention in Atrial Fibrillation – Outcomes and Future Directions
Stroke prevention is central to the management of patients with atrial fibrillation (AF). Vitamin K antagonists (VKAs) are the established and long-standing option for stroke prevention therapy in patients with AF. However, non-VKA oral anticoagulants (NOACs) have recently been developed and demonst...
Uloženo v:
| Vydáno v: | Arrhythm Electrophysiol Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Radcliffe Cardiology
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4711502/ https://ncbi.nlm.nih.gov/pubmed/26835091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/aer.2014.3.3.194 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|